Serono Responds To Infertility Discounting With Gonal-f DTC Ads
This article was originally published in The Pink Sheet Daily
Executive Summary
Serono is aiming to offset heavy competitive discounting in the infertility treatment market through expansion of direct-to-consumer advertising and support programs for its Gonal-f therapy, the company said
You may also be interested in...
Serono Educational Efforts Turn To Brooke Shields
Educational campaign is part of effort to combat continued pricing pressures in the infertility segment from Organon.
Metsera Launches As New Obesity Contender Flush With $290m
Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture.